InvestorsHub Logo
Followers 18
Posts 2050
Boards Moderated 0
Alias Born 03/25/2013

Re: None

Monday, 12/18/2017 6:15:27 PM

Monday, December 18, 2017 6:15:27 PM

Post# of 430312
Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's president and chief executive officer, is scheduled to present a general company update at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2018, at 5:00 p.m. PST / 8:00 p.m. EST
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News